Darlene Dobkowski, MA

Patients with pancreatic and gastric cancers residing in states with expanded Medicaid had improved survival rates.

Tisagenlecleucel evoked similar efficacy and a preferrable safety profile in children and adults with B-ALL being treated in a real-world analysis, compared with the clinical trial ELIANA.

Findings presented at the 2021 San Antonio Breast Cancer Symposium suggest that Certain adverse effects associated with olaparib were minimal and resolved with appropriate management in patients with breast cancer.

Characteristics such as low positive PD-L1 expression and rare high positive staining were identified in both patients with VHL-mutated and VHL wild type clear cell renal cell carcinoma.

Due to the favorable efficacy and safety profiles of daratumumab plus lenalidomide and dexamethasone, researchers speculate that the combination may become the new standard of care in multiple myeloma treatment.

Patients with myeloma and a negative MRD may be at a reduced risk of mortality and other progression-free survival events.

Amanpour, who is CNN's chief international anchor, announced her diagnosis live on-air, while advocating for cancer screening, too.

CURE Media Group also recognized Jennifer E. Giovanni, PhD, MSN, MPH, RN, as winner of the Finest Hour Award, which highlights the dedi- cation and selflessness exhibited in frontline workers during the COVID-19 pandemic.

States without Medicaid expansion tended to have poorer cancer outcomes than states with higher income limits on eligibility, according to recent research.

A clinic for patients with a history of cancer led by an advanced practice nurse and a dietician may empower patients to improve their lifestyles through diet and exercise, especially since it may have an impact on their outcomes and future risk for diseases.

Although survivors and patients with lung cancer felt that they were involved in the treatment decision-making process, nearly half of them reported that they knew what their treatment options were before making a decision, according to results from a study presented at the 2020 World Conference on Lung Cancer Singapore.

Findings from an analysis determined that stage 4 gastrointestinal stromal tumors were rare and led to hepatic metastases, although overall survival was up to 51% at 5 years.